Sun Pharma Advanced Research Company Limited — Board Meeting, 04-08-2025: Outcome of Board Meeting

SPARC's Board of Directors approved the financial results for the first quarter ended June 30, 2025. The focus was on the consolidated figures, providing investors with an update on the company's performance. No other key decisions like dividends, fundraising, or strategic changes were announced at this meeting.